Literature DB >> 20134308

Outcomes of a standardized surgical and rehabilitation program in transtibial amputation for peripheral vascular disease: a prospective cohort study.

Anton Johannesson1, Gert-Uno Larsson, Nerrolyn Ramstrand, Henrik Lauge-Pedersen, Philippe Wagner, Isam Atroshi.   

Abstract

OBJECTIVE: To study the outcomes of a new surgical and rehabilitation program for initial unilateral transtibial amputation in patients with peripheral vascular disease. The program consists of sagittal incision, rigid dressing, compression therapy using silicone liner, and direct manufacturing prosthetic technique.
DESIGN: A prospective cohort study with 1-yr follow-up.
RESULTS: Of the 217 consecutive patients with peripheral vascular disease who underwent transtibial amputation (mean age, 77 yrs; 51% diabetic; 116 could walk before amputation), 119 (55%) were fitted with a prosthesis at a median time of 41 (range, 12-147) days after amputation. Of the prosthetic recipients, 76 (64%) obtained good function with the prosthesis within 6 mos. Within 1 yr, reamputation was performed on 8.2%, and contralateral amputation was performed on 5.5%. The 90-day mortality was 24% (53 patients). The total 1-yr mortality was 40% (86 patients): 17% among patients who received a prosthesis and 67% among those who did not receive a prosthesis or had undergone reamputation.
CONCLUSIONS: Following this standardized surgical and rehabilitation program, prosthetic fitting was achieved in more than half of transtibial amputees, almost two-thirds of prosthetic recipients obtained good function, and the reamputation rate was low. Comparison with outcomes of alternative strategies is needed.

Entities:  

Mesh:

Year:  2010        PMID: 20134308     DOI: 10.1097/PHM.0b013e3181cf1bee

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  8 in total

1.  Rigid dressings versus soft dressings for transtibial amputations.

Authors:  Li Khim Kwah; Matthew T Webb; Lina Goh; Lisa A Harvey
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

2.  Patient-, treatment-, and facility-level structural characteristics associated with the receipt of preoperative lower extremity amputation rehabilitation.

Authors:  Barbara E Bates; Richard Hallenbeck; Toni Ferrario; Pui L Kwong; Jibby E Kurichi; Margaret G Stineman; Dawei Xie
Journal:  PM R       Date:  2012-08-30       Impact factor: 2.298

3.  Effects of prosthetic limb prescription on 3-year mortality among Veterans with lower-limb amputation.

Authors:  Jibby E Kurichi; Pui Kwong; W Bruce Vogel; Dawei Xie; Diane Cowper Ripley; Barbara E Bates
Journal:  J Rehabil Res Dev       Date:  2015

4.  An enhanced treatment program with markedly reduced mortality after a transtibial or higher non-traumatic lower extremity amputation.

Authors:  Morten T Kristensen; Gitte Holm; Michael Krasheninnikoff; Pia S Jensen; Peter Gebuhr
Journal:  Acta Orthop       Date:  2016-04-18       Impact factor: 3.717

5.  The impact of gender, level of amputation and diabetes on prosthetic fit rates following major lower extremity amputation.

Authors:  Fiona Davie-Smith; Lorna Paul; Natalie Nicholls; Wesley P Stuart; Brian Kennon
Journal:  Prosthet Orthot Int       Date:  2016-07-09       Impact factor: 1.895

6.  Use-dependent increase in attention to the prosthetic foot in patients with lower limb amputation.

Authors:  Naoki Aizu; Yutaka Oouchida; Kouji Yamada; Kazuhiro Nishii; Shin-Ichi Izumi
Journal:  Sci Rep       Date:  2022-07-23       Impact factor: 4.996

Review 7.  Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis.

Authors:  Rongqi Liu; Brian J Petersen; Gary M Rothenberg; David G Armstrong
Journal:  BMJ Open Diabetes Res Care       Date:  2021-06

8.  Results of prosthetic rehabilitation on managing transtibial vascular amputation with silicone liner after wound closure.

Authors:  Takaaki Chin; Mitsunori Toda
Journal:  J Int Med Res       Date:  2016-05-25       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.